Objectives: to examine the effect of vitamin D supplementation on glycaemic control and percentage of body fat mass in prediabetic individuals.
Design: a single blind, randomized placebo- controlled trial. Sample size was 120 prediabetic adults.
Setting and conduct: the subjects using stratified block randomization according to percentage of body fat mass randomly assigned in intervention group (1000 IU/daily vitamin D) or placebo group (placebo tablet) for 3 months.
Participants: Participants were adults aged 18-70 years old with prediabetes. exclusion criteria including: type 1 or type 2 diabetes, kidney diseases, sarcoidosis, cancers, hyperparathyroidism, heart diseases, liver diseases, pregnant and breastfeeding, hypercalcaemia, inflammatory bowel disease, cystic fibrosis, gastric bypass surgery, cholecystectomy, and patients who changed their lifestyle and dietary habits during the intervention period. Fasting blood glucose (FBS), Glycated hemoglobin (HbA1c), homeostasis model assessment of insulin resistance (HOMA-IR), serum 25(OH)D levels, and percentage fat mass (FM) were assessed before and after the intervention in both groups.